JANE STREET GROUP, LLC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L951. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$73,500
-97.7%
17,500
-96.9%
0.00%
-100.0%
Q3 2022$3,264,000
+1319.1%
560,800
+1352.8%
0.00%
Q2 2022$230,00038,6000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 5,700$34,2570.00%
SIMPLEX TRADING, LLC 9,800$580.00%
View complete list of CTI BIOPHARMA CORP shareholders